The Report Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices,
Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug
Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders,
Oncology), By End-user Application (Hospitals, Homecare Settings, Research
Institutes, Clinical Laboratories), By Region (U.S, Canada, Germany, U.K,
China, India, South Africa, Saudi Arabia, Brazil, Mexico) And Segment Forecasts
From 2018 to 2024
The global Injectable Drug Delivery
Market is expected to reach USD 931.1 billion by 2024, according to a new
report by Grand View Research, Inc. The increase in number of chronic diseases
like diabetes and cancer has fueled the need for injectable drug delivery.
Unlike other traditional forms of drug delivery, injectables allow maximum
bioavailability of the pharmaceutical drug as it bypasses the first pass
metabolism. With substantial growth in technological advancements, the devices
being manufactured and marketed are built so as to cater to the specific needs
of the patients.
With
the advent of self-injection devices, injectable drugs can be self administered
without the need of medical assistance. A large number of technology-oriented
developments have taken place in the biologics market, which further increases
the applicability of these injectable devices in the challenging disease areas.
Self-injection devices have allowed patients suffering from diabetes to manage
insulin levels with auto-injectors, pen-injectors, and needle-free injectors;
thus, the homecare segment has been a large grosser in the end-user
application.
The
major restraints in this market are injuries and infections caused by needles,
ambiguities related to regulatory reimbursements, sterility of the injectable
drugs, and the preference of other drug delivery systems that possess less toxicity
and are easy to administer. Despite these restraints, the market potential for
injectable drug delivery products is tremendous with majority of the key
players opting to injectables over other forms of delivery. The injectable drug
delivery industry, based on product type is segmented into two sub-types namely
self-injection devices and conventional injection devices. Further, on the
basis of therapeutic use, the injectable drug delivery industry is segmented
into autoimmune disorders, hormonal disorders, oncology, and others.
The
injectable drug delivery industry by end-user application is categorized into
hospitals, homecare settings, and others including research establishments,
diagnostics, and clinical laboratories.
Access Research Report of Injectable Drug Delivery Market @ www.grandviewresearch.com/industry-analysis/injectable-drug-delivery-devices-industry
Further key findings
from the study suggest:
· North America is expected to lead the market for
injectable drug delivery devices with the largest number of patients suffering
from chronic diseases like diabetes and cancer along with autoimmune disorders.
The reason why countries in North America are leading is due to the
technological innovations and advanced research in the area that enable them to
excel at designing new and improved drug delivery products.
· The Asia Pacific market is set to lead exceptionally well
owing to the partnerships with other well established global players. This
region has also witnessed enormous investments in research and development;
thus, accelerating the growth of the injectables market in this region.
· The homecare settings has been the most profit garnering
segment with a large cohort of patients suffering from chronic diseases and
hence the resultant high utility of these devices at a primary level for better
control and management of the disease.
· Some key market players include Pfizer, Inc., Schott AG,
Becton, Dickinson and Company, Baxter International, Inc., and ELI Lilly &
Co.
Grand View Research has segmented the global injectable
drug delivery market on the basis of device type, therapeutic use, formulation,
end-user application, and region:
Injectable Drug Delivery
by Type Outlook (Revenue, USD Million, 2013 - 2024)
·
Devices
o Self-
injection devices
o Conventional
injection devices
·
Formulation
o Conventional
Drug Delivery
o Novel
Drug Delivery
o Others
Injectable Drug Delivery
Therapeutic Use Outlook (Revenue, USD Million, 2013 - 2024)
·
Autoimmune disorders
·
Hormonal disorders
·
Oncology
·
Others
Injectable Drug Delivery
Devices End-User Application Outlook (Revenue, USD Million, 2013 - 2024)
·
Hospitals
·
Homecare Settings
·
Others
Injectable Drug Delivery
Devices Regional Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access
Press Release of Injectable Drug Delivery
Market @ www.grandviewresearch.com/press-release/global-injectable-drug-delivery-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
